TNF and breast cancer: In primary breast tumor and metastatic sites, TRAIL is released by BC cells, activated fibroblasts, macrophages, lymphocytes and post- TNF-α/interferon-α/-γ stimulated mesenchymal stem cells (MSCs) [8,43,45,50].